BIOMAT Database Logo BIOMAT Database Logo

Erythropoietic protoporphyria and iron therapy. 1990

B M McClements, and A Bingham, and M E Callender, and E R Trimble

UI MeSH Term Description Entries
D007501 Iron A metallic element with atomic symbol Fe, atomic number 26, and atomic weight 55.85. It is an essential constituent of HEMOGLOBINS; CYTOCHROMES; and IRON-BINDING PROTEINS. It plays a role in cellular redox reactions and in the transport of OXYGEN. Iron-56,Iron 56
D011164 Porphyrias A diverse group of metabolic diseases characterized by errors in the biosynthetic pathway of HEME in the LIVER, the BONE MARROW, or both. They are classified by the deficiency of specific enzymes, the tissue site of enzyme defect, or the clinical features that include neurological (acute) or cutaneous (skin lesions). Porphyrias can be hereditary or acquired as a result of toxicity to the hepatic or erythropoietic marrow tissues. Porphyria,Porphyrin Disorder,Disorder, Porphyrin,Disorders, Porphyrin,Porphyrin Disorders
D004920 Erythropoiesis The production of red blood cells (ERYTHROCYTES). In humans, erythrocytes are produced by the YOLK SAC in the first trimester; by the liver in the second trimester; by the BONE MARROW in the third trimester and after birth. In normal individuals, the erythrocyte count in the peripheral blood remains relatively constant implying a balance between the rate of erythrocyte production and rate of destruction. Erythropoieses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

B M McClements, and A Bingham, and M E Callender, and E R Trimble
Erythropoietic protoporphyria provoked by iron therapy.
June 1971, Proceedings of the Royal Society of Medicine,
B M McClements, and A Bingham, and M E Callender, and E R Trimble
Erythropoietic protoporphyria exacerbated by oral iron therapy.
July 1988, The British journal of dermatology,
B M McClements, and A Bingham, and M E Callender, and E R Trimble
Iron therapy for hepatic dysfunction in erythropoietic protoporphyria.
July 1986, Annals of internal medicine,
B M McClements, and A Bingham, and M E Callender, and E R Trimble
A pilot study of oral iron therapy in erythropoietic protoporphyria and X-linked protoporphyria.
December 2022, Molecular genetics and metabolism reports,
B M McClements, and A Bingham, and M E Callender, and E R Trimble
PUVA therapy for erythropoietic protoporphyria.
June 1988, Photo-dermatology,
B M McClements, and A Bingham, and M E Callender, and E R Trimble
Transfusion therapy for erythropoietic protoporphyria.
November 1983, The British journal of dermatology,
B M McClements, and A Bingham, and M E Callender, and E R Trimble
Erythrocyte protoporphyrin and iron uptake in erythropoietic protoporphyria.
October 1971, Clinical science,
B M McClements, and A Bingham, and M E Callender, and E R Trimble
Homeostasis of iron and hepcidin in erythropoietic protoporphyria.
October 2015, European journal of clinical investigation,
B M McClements, and A Bingham, and M E Callender, and E R Trimble
Erythropoiesis and iron metabolism in dominant erythropoietic protoporphyria.
December 2007, Blood,
B M McClements, and A Bingham, and M E Callender, and E R Trimble
Symptomatic response of erythropoietic protoporphyria to iron supplementation.
June 2007, Journal of the American Academy of Dermatology,
Copied contents to your clipboard!